Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
Clinical trial NCT03071081 · COMPLETED
Trial details
- NCT number
- NCT03071081
- Sponsor
- Topivert Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2017-06-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.